Phase III Study Shows Combination Treatment to be Effective for NSCLC

This study found that carboplatin-pemetrexed treatment followed by pemetrexed maintenance was a valid option for first-line treatment of elderly patients with advanced nonsquamous non-small cell lung cancer.

Source: CancerNetwork - March 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news